Grazia Chiellini - Concepedia

Author

Grazia Chiellini

Also Known As

CHIELLINI, GRAZIA, Chiellini, G., Chiellini, Grazia, G CHIELLINI, G Chiellini, G. CHIELLINI, G. Chiellini, Grazia Chiellini

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of Pisa University of Wisconsin–Madison University of California, San Francisco Oregon Health & Science University University of Cagliari

About

Grazia Chiellini is an author at University of Pisa specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.2K
2	Health Sciences	6	6	319
3	Natural Sciences	4	4	122
4	Engineering	1	1	38
5	Public Health	1	1	439

Grazia Chiellini

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone Thomas S. Scanlan, Katherine L. Suchland, Matthew Hart, Nature Medicine Molecular PharmacologyMedicineIodine Deficiency DisordersPhysiologyThyroid Disease	2004	439
The Thyroid Hormone Receptor-β-Selective Agonist GC-1 Differentially Affects Plasma Lipids and Cardiac Activity<sup>1</sup> Susanne U. Trost, Eric A. Swanson, Bernd Gloss, Endocrinology	2000	272
Effects of the Thyroid Hormone Receptor Agonist GC-1 on Metabolic Rate and Cholesterol in Rats and Primates: Selective Actions Relative to 3,5,3′-Triiodo-<scp>l</scp>-Thyronine Gary J. Grover, Donald Egan, Paul G. Sleph, Endocrinology Metabolic RateObesityMolecular PharmacologyMetabolic SyndromeSelective Actions	2004	162
Memantine prodrug as a new agent for Alzheimer’s Disease Simona Sestito, Simona Daniele, Deborah Pietrobono, Scientific Reports	2019	80
Cardiac effects of trace amines: Pharmacological characterization of trace amine-associated receptors Sabina Frascarelli, Sandra Ghelardoni, Grazia Chiellini, European Journal of Pharmacology Heart FailureCardiac EffectsMedicinePhysiologyCardiovascular Pharmacology	2008	66
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis Massimiliano Runfola, Simona Sestito, Lorenza Bellusci, European Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryDrug TargetBiochemistryNatural Sciences	2019	54
Dual Inhibition of PDK1 and Aurora Kinase A: An Effective Strategy to Induce Differentiation and Apoptosis of Human Glioblastoma Multiforme Stem Cells Simona Daniele, Simona Sestito, Deborah Pietrobono, ACS Chemical Neuroscience Chemoprevention StrategyApoptosisCell DeathGsc SubpopulationHigh-grade Gliomas	2016	53
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection Lorenza Bellusci, Annunziatina Laurino, Martina Sabatini, Frontiers in Pharmacology	2017	44
In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine Annunziatina Laurino, Gaetano De Siena, Alessandro Saba, European Journal of Pharmacology 3-Iodothyroacetic AcidNeurophysiologyMedicineIodine Deficiency DisordersPhysiology	2015	42
Effect of alpha-fluorination of valproic acid on valproyl-S-acyl-CoA formation in vivo in rats. Mark P. Grillo, Grazia Chiellini, Marco Tonelli, PubMed Valproic AcidPharmacological StudyBiochemistryMedicineLiver Physiology	2001	41

Page 1